Similarly, Arnab et al. (19) reported that anti-CCP antibodies were associated with markers of atherosclerosis and cardiac dysfunction, and Bakry et al. (20) underscored the role of cytokines, including IL-1β, IL-6, and IL-18, in the risk of ischemic heart disease. Here, IL18 is linked to atherosclerosis.